Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Acquisitions (2017)

Historic Acquisitions for Viridian Therapeutics, Inc.\DE (VRDN) over the last 1 years, with Q1 2017 value amounting to $1.3 million.

  • Viridian Therapeutics, Inc.\DE's Acquisitions changed N/A to $1.3 million in Q1 2017 from the same period last year, while for Dec 2017 it was $1.3 million, marking a year-over-year change of. This contributed to the annual value of $29.4 million for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q1 2017, Viridian Therapeutics, Inc.\DE's Acquisitions is $1.3 million.
  • Viridian Therapeutics, Inc.\DE's 5-year Acquisitions high stood at $1.3 million for Q1 2017, and its period low was $1.3 million during Q1 2017.